HIV/AIDS Research and Treatment Advances
HIV remains a major global health challenge, but treatment has turned it into a manageable long-term condition for many people. Research continues on better medicines, prevention, long-term health and a possible cure.
The HIV/AIDS Research and Treatment Advances session at Infectious 2027 covers the science and care of HIV. It links closely with STD and HIV infection, which looks at HIV alongside other sexually transmitted infections.
With effective treatment, people with HIV can live long, healthy lives and cannot pass the virus to sexual partners. Testing and early treatment are key to these benefits. Prevention tools such as PrEP are reducing new infections. Yet millions of people still lack access to testing and care.
Key Topics in HIV/AIDS Research and Treatment Advances
• Antiretroviral therapy and new drugs
• Long-acting injectable treatment
• Pre-exposure prophylaxis (PrEP)
• HIV drug resistance
• HIV cure and remission research
• HIV vaccine research
• Opportunistic infections and co-infections
• Ageing with HIV
• Stigma and access to care
• HIV in key populations
Recent Advances in HIV/AIDS Research and Treatment Advances
Long-acting injectable treatments and PrEP given every few months are making treatment and prevention easier. Cure research is exploring gene editing and immune approaches, building on molecular biology and genomics.
People with HIV are living longer, and ageing with HIV is a growing area of care linked with geriatric infectious diseases. Reducing stigma and improving access, discussed in socioeconomic determinants of infectious diseases, remain key to ending the epidemic.
Long-acting injections are offering alternatives to daily pills for treatment and prevention. Research on HIV cure is exploring ways to clear or control the virus without lifelong medicine. Community-led services are reaching people who avoid clinics. Programmes are also addressing the health needs of people ageing with HIV.
Who Should Attend the HIV/AIDS Research and Treatment Advances Session
• HIV physicians and infectious disease specialists
• Nurses, pharmacists and HIV care teams
• Researchers in virology and immunology
• Public health and prevention professionals
• PhD students and early-career researchers
• Community organisations and advocates
Why Present Your Research in HIV/AIDS Research and Treatment Advances
Presenting at Infectious 2027 puts your HIV research in front of clinicians and researchers worldwide. You can connect with colleagues in psychosocial aspects of infectious disease management working on stigma and mental health. HIV research brings together clinicians, scientists and communities. Your work can help close the remaining gaps in prevention and care.
Frequently Asked Questions
Can I present PrEP programme results?
Yes. PrEP and prevention programme studies are welcome.
Does this session cover HIV cure research?
Yes. Cure and remission research are key topics.
When and where is Infectious 2027?
Infectious 2027 takes place from 11 to 13 March 2027 at Village Hotel Changi, Singapore, and online.